ModivCare (MODV) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for June 17, 2025, to elect seven directors, approve executive compensation, and ratify KPMG as auditor.
Company maintained consistent revenue in 2024 despite market disruptions, with strategic investments in technology and leadership.
Executive compensation aligns with performance, with no short-term incentive payouts in 2024 due to missed EBITDA targets.
Sustainability and inclusivity are emphasized, with a published 2023 Sustainability Report and ongoing ESG initiatives.
Voting matters and shareholder proposals
Proposals include election of seven directors, advisory vote on executive compensation, and ratification of KPMG as auditor.
Board recommends voting FOR all proposals.
Shareholder proposals for the 2026 meeting must be submitted by December 31, 2025.
Board of directors and corporate governance
Board consists of seven members, with separation of Chair and CEO roles.
All committees are chaired by independent directors; majority of directors are independent.
Four standing committees: Audit, Compensation, Nominating and Governance, and Strategic Alternatives.
Strategic Alternatives Committee oversees planned divestitures and cost optimization.
Annual board and committee self-evaluations and regular executive sessions of non-employee directors.
Latest events from ModivCare
- Q2 2024 revenue flat at $698.3M, net loss $128.9M, Adjusted EBITDA $45.4M, RPM impairment.MODV
Q2 20242 Feb 2026 - Margin expansion and digital transformation position the business for growth and stability.MODV
Jefferies Global Healthcare Conference1 Feb 2026 - Revenue up 2.2% to $702M, net loss widens, liquidity risks persist, 2024 guidance affirmed.MODV
Q3 202416 Jan 2026 - Q2 2025 loss deepened to $303.7M amid bankruptcy, restructuring, and major goodwill impairment.MODV
Q2 202529 Dec 2025 - Chapter 11 restructuring confirmed; revenue and membership down, equity to be canceled.MODV
Q3 202529 Dec 2025 - Healthcare services firm files $200M shelf for flexible equity, debt, and warrant offerings.MODV
Registration Filing16 Dec 2025 - Revenue up 1.3% to $2.79B, but losses and margin pressures persist amid industry disruption.MODV
Q4 202412 Dec 2025 - $105M in new financing, board changes, and a strategic review aim to stabilize operations.MODV
Proxy Filing1 Dec 2025 - Stockholders to vote on $30M note issuance and $20.165M exchange to bolster financial position.MODV
Proxy Filing1 Dec 2025